Azeliragon Clinical Trials

1 actively recruiting trial across 1 location

▼ -2 trials since June 2026

Also known as: PF-04494700, TTP488

Pipeline

Early 1: 1

Top Sponsors

Washington University School of Medicine1

Indications

Glioblastoma1
Cancer1

St Louis, Missouri1 trial

Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma

Washington University School of Medicine

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.